QGEN Butterfly Strategy
QGEN (Qiagen N.V.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors.
QGEN (Qiagen N.V.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $8.86B, a trailing P/E of 21.65, a beta of 0.62 versus the broader market, a 52-week range of 32.53-57.82, average daily share volume of 2.5M, a public-listing history dating back to 1996, approximately 6K full-time employees. These structural characteristics shape how QGEN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates QGEN has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. QGEN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a butterfly on QGEN?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
QGEN snapshot
As of August 14, 2026, spot at $42.97, ATM IV 43.80%, IV rank 20.53%, expected move 12.56%. The butterfly on QGEN below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on QGEN specifically: QGEN IV at 43.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a QGEN butterfly, with a market-implied 1-standard-deviation move of approximately 12.56% (roughly $5.40 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated QGEN expiries trade a higher absolute premium for lower per-day decay. Position sizing on QGEN should anchor to the underlying notional of $42.97 per share and to the trader's directional view on QGEN stock.
QGEN butterfly setup
The QGEN butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With QGEN at $42.97 on that close, the first option leg uses a $40.82 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed QGEN chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 QGEN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $40.82 | N/A |
| Sell 2 | Call | $42.97 | N/A |
| Buy 1 | Call | $45.12 | N/A |
QGEN butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
QGEN butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on QGEN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on QGEN
Butterflies on QGEN are pinning bets - traders use them when they expect QGEN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
QGEN thesis for this butterfly
The market-implied 1-standard-deviation range for QGEN extends from approximately $37.57 on the downside to $48.37 on the upside. A QGEN long call butterfly is a pinning play: it pays maximum at the middle strike if QGEN settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current QGEN IV rank near 20.53% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on QGEN at 43.80%. As a Healthcare name, QGEN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to QGEN-specific events.
QGEN butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. QGEN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move QGEN alongside the broader basket even when QGEN-specific fundamentals are unchanged. Always rebuild the position from current QGEN chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on QGEN?
- A butterfly on QGEN is the butterfly strategy applied to QGEN (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With QGEN stock at $42.97 on the most recent close, the strikes shown on this page are snapped to the nearest listed QGEN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are QGEN butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the QGEN butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 43.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a QGEN butterfly?
- The breakeven for the QGEN butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The QGEN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 12.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on QGEN?
- Butterflies on QGEN are pinning bets - traders use them when they expect QGEN to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current QGEN implied volatility affect this butterfly?
- QGEN ATM IV is at 43.80% with IV rank near 20.53%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.